A new study involving the blood thinner Pradaxa indicates that patients taking the medication to reduce their risk of blood clots and stroke may actually put themselves at risk of suffering from other life-threatening side effects, including heart disease. Pradaxa (dabigatran etexilate mesylate) has been available in the United States as an anticoagulant medication since October 2010, and is currently manufactured by Boehringer Ingelheim. Pradaxa is commonly prescribed to patients diagnosed with non-valvular atrial fibrillation (AF), a common heart rhythm abnormality that occurs when a part of the heart doesn’t beat like it should. Unfortunately, recent Pradaxa side effect information has raised serious doubts about the safety of Pradaxa, particularly in patients with AF. If you took Pradaxa and have since experienced heart disease side effects, contact a Pradaxa attorney today to discuss your legal options.
Coronary heart disease is a narrowing of the small blood vessels that supply the heart with blood and oxygen. Chest pain or discomfort is the most common symptom of heart disease. Other symptoms of heart disease may include:
In some heart disease victims, the symptoms of the condition may be very noticeable, although some people may have the disease without experiencing any symptoms.
The appropriate treatment for heart disease depends on the patient’s symptoms and how severe the disease is. Common procedures and surgeries used to treat heart disease include minimally invasive heart surgery, coronary artery bypass surgery, and angioplasty and stent placement. Although all patients with heart disease are different, early detection of heart disease typically results in a better outcome.
The most significant concern regarding the safety of the anticoagulant Pradaxa is its potential to cause life-threatening internal bleeding in patients. In fact, the FDA issued a drug safety communication on December 7, 2011, indicating that the agency was evaluating post-marketing reports of serious bleeding events in patients taking Pradaxa. Although the FDA admits that bleeding that may lead to serious or even fatal outcomes is a well-known complication of all anticoagulant therapies, internal bleeding associated with blood thinners like warfarin can typically be treated with vitamin K. Unfortunately, there is currently no antidote for internal bleeding caused by Pradaxa and other direct thrombin inhibitors.
Another danger that has gained public attention recently is the potential for Pradaxa to lead to cardiovascular side effects like heart disease. According to a new study published in the Archives of Internal Medicine, patients taking Pradaxa to minimize their risk of stroke and blood clots may have a 33% increased risk of experiencing a heart attack or severe symptoms of heart disease, compared to patients taking the blood thinner warfarin.
Coronary heart disease is the leading cause of death in the United States for both men and women. If you or a loved one has suffered from heart disease, which you believe to be associated with the anticoagulant Pradaxa, contact a Pradaxa attorney immediately. You may have grounds to file a Pradaxa lawsuit against drug firm Boehringer Ingelheim, in order to pursue financial compensation for your injuries, medical bills, and pain and suffering. Furthermore, if you lost a loved one to Pradaxa-related heart disease, you may be entitled to reimbursement for funeral costs, emotional suffering, and other associated expenses. You are not at fault for any serious side effects caused by a pharmaceutical drug, and you should not be held accountable for the resulting consequences. By hiring a qualified Pradaxa lawyer to represent your case, you can collect the compensation you deserve and protect yourself from further harm.